Immunization of Rabbits with Recombinant Human Cytomegalovirus Trimeric versus Monomeric gH/gL Protein Elicits Markedly Higher Titers of Antibody and Neutralization Activity

Development of novel vaccines against human cytomegalovirus

(2019) Xinle Cui et al.   Human Vaccines & Immunotherapeutics

HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions

(2018) Cody S. Nelson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies

(2018) Ilona Baraniak et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity

(2018) Shinu John et al.   VACCINE

Distinct Immunologic Properties of Soluble Versus Particulate Antigens

(2018) Clifford M. Snapper   Frontiers in Immunology

An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor

(2018) Nadia Martinez-Martin et al.   CELL

A fifty-year odyssey: Prospects for a cytomegalovirus vaccine in transplant and congenital infection

(2018) Don J. Diamond et al.   Expert Review of Vaccines

Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice

(2018) Flavia Chiuppesi et al.   JOURNAL OF VIROLOGY

Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response

(2018) Xinle Cui et al.   VACCINE

A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection

(2018) Cody S. Nelson et al.   npj Vaccines

Role of PDGF receptor-α during human cytomegalovirus entry into fibroblasts

(2018) Kai Wu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

(2017) Francisco M. Marty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy

(2017) Lin Xia et al.   Human Vaccines & Immunotherapeutics

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

(2017) Anna Bootz et al.   PLoS Pathogens

A derivative of platelet-derived growth factor receptor alpha binds to the trimer of human cytomegalovirus and inhibits entry into fibroblasts and endothelial cells

(2017) Cora Stegmann et al.   PLoS Pathogens

Human cytomegalovirus glycoprotein complex gH/gL/gO uses PDGFR-α as a key for entry

(2017) Yiquan Wu et al.   PLoS Pathogens

A replication-defective human cytomegalovirus vaccine for prevention of congenital infection

(2016) D. Wang et al.   Science Translational Medicine

Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350

(2016) Xinle Cui et al.   VACCINE

Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial

(2016) David I. Bernstein et al.   VACCINE

Human Cytomegalovirus gH/gL Forms a Stable Complex with the Fusion Protein gB in Virions

(2016) Adam L. Vanarsdall et al.   PLoS Pathogens

Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell Transplantation

(2016) Matthias J. Reddehase   Frontiers in Immunology

Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer

(2016) Anna Kabanova et al.   Nature Microbiology

Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection

(2015) Flavia Chiuppesi et al.   JOURNAL OF VIROLOGY

Development of CpG-Oligodeoxynucleotides for Effective Activation of Rabbit TLR9 Mediated Immune Responses

(2014) Tsung-Hsien Chuang et al.   PLoS One

Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies

(2014) Anna Kabanova et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109

(2014) A. E. Fouts et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease

(2014) Tong-Ming Fu et al.   VACCINE

Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice

(2014) Yingxia Wen et al.   VACCINE

HCMV Infection of Human Trophoblast Progenitor Cells of the Placenta Is Neutralized by a Human Monoclonal Antibody to Glycoprotein B and Not by Antibodies to the Pentamer Complex

(2014) Martin Zydek et al.   Viruses-Basel

Human Cytomegalovirus Vaccine Based on the Envelope gH/gL Pentamer Complex

(2014) Felix Wussow et al.   PLoS Pathogens

Cytomegalovirus diseases after hematopoietic stem cell transplantation: A mini-review

(2013) Ella J. Ariza-Heredia et al.   CANCER LETTERS

Cytomegalovirus vaccine: phase II clinical trial results

(2013) F. Rieder et al.   CLINICAL MICROBIOLOGY AND INFECTION

The “Silent” Global Burden of Congenital Cytomegalovirus

(2013) Sheetal Manicklal et al.   CLINICAL MICROBIOLOGY REVIEWS

Management Strategies for Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients

(2013) Raymund R. Razonable   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine

(2013) D. C. Freed et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Priorities for CMV vaccine development

(2013) Philip R. Krause et al.   VACCINE

A novel tetrameric gp3501–470 as a potential Epstein–Barr virus vaccine

(2013) Xinle Cui et al.   VACCINE

Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies

(2012) Rebecca J. Loomis et al.   VACCINE

HCMV gB shares structural and functional properties with gB proteins from other herpesviruses

(2012) Sapna Sharma et al.   VIROLOGY

Cytomegalovirus in Solid Organ Transplantation: Epidemiology, Prevention, and Treatment

(2012) Elena Beam et al.   Current Infectious Disease Reports

Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected Women

(2011) Steffanie Sabbaj et al.   JOURNAL OF INFECTIOUS DISEASES

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

(2011) Paul D Griffiths et al.   LANCET

Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells

(2011) Frances M. Saccoccio et al.   VACCINE

Congenital Cytomegalovirus Mortality in the United States, 1990–2006

(2011) Benjamin N. Bristow et al.   PLoS Neglected Tropical Diseases

Management of cytomegalovirus infection in solid organ transplantation

(2010) Camille N. Kotton   Nature Reviews Nephrology

Congenital cytomegalovirus: Public health action towards awareness, prevention, and treatment

(2009) Gail J. Demmler-Harrison   JOURNAL OF CLINICAL VIROLOGY

Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex

(2009) A. Macagno et al.   JOURNAL OF VIROLOGY

Vaccine Prevention of Maternal Cytomegalovirus Infection

(2009) Robert F. Pass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Structure of a trimeric variant of the Epstein–Barr virus glycoprotein B

(2009) Marija Backovic et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Entry of herpesviruses into mammalian cells

(2008) E. E. Heldwein et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme

(2008) Judith M. White et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY